Document is current
Any future updates will be listed below
-
Authors
Pauwels, Elin https://orcid.org/0000-0002-3296-8011
Celen, Sofie https://orcid.org/0000-0002-6742-7469
Baete, Kristof https://orcid.org/0000-0003-0113-1590
Koole, Michel
Bechter, Oliver
Bex, Marie
Renard, Marleen
Clement, Paul M.
Jentjens, Sander
Serdons, Kim
Van Laere, Koen https://orcid.org/0000-0001-5200-7245
Bormans, Guy https://orcid.org/0000-0002-0335-7190
Deroose, Christophe M. https://orcid.org/0000-0002-6080-1577
- License Information
-
More Information
Article History
Received: 9 August 2022
Accepted: 13 November 2022
First Online: 26 November 2022
Declarations
:
: This study was performed in line with the principles of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was granted by the Ethics Committee Research UZ/KU Leuven (28 January 2020/S63142).
: Written informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the images in Figs. and .
: Paul M. Clement received study budget funds from AstraZeneca and was an advisory board member for AbbVie, AstraZeneca, Bayer, BMS, Daiichi-Sankyo, Leo Pharma, Merck Serono, MSD, Rakuten, Takeda, and Vifor Pharma, outside the scope of the submitted work. Christophe M. Deroose has been a consultant for Terumo, Ipsen, Sirtex, Bayer, and PSI CRO outside the scope of the submitted work. There are no other conflicts of interest.
